# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stephens & Co. analyst Terry McEvoy reiterates Comerica (NYSE:CMA) with a Overweight and maintains $58 price target.
DA Davidson analyst Peter Winter maintains Comerica (NYSE:CMA) with a Neutral and maintains $55 price target.
Keefe, Bruyette & Woods analyst Christopher Mcgratty upgrades Comerica (NYSE:CMA) from Market Perform to Outperform and ...
Morgan Stanley analyst Manan Gosalia maintains Comerica (NYSE:CMA) with a Equal-Weight and raises the price target from $50 ...
Morgan Stanley analyst Manan Gosalia maintains Comerica (NYSE:CMA) with a Equal-Weight and lowers the price target from $53 ...
Comerica reported Q2 results broadly in-line with expectations but reduced its guidance. Analysts provide mixed views.
RBC Capital analyst Jon Arfstrom maintains Comerica (NYSE:CMA) with a Outperform and lowers the price target from $58 to $56.